Dahlke, Marion

Novartis (Switzerland)

1 paper on CoChatORCID 0009-0008-1360-6382

Most cited papers

Verified
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
Heerspink, H. J. L., Jardine, M. J., Kohan, D. E., Lafayette, R., Levin, A., Liew, A., Zhang, H., Noronha, I. L., Mastroianni-Kirsztajn, G., Chow, S., et al. (2026) · The Lancet
Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes
Cited by 12

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free